Cargando…
Effect of histology on stereotactic body radiotherapy for non-small cell lung cancer oligometastatic pulmonary lesions
BACKGROUND: Stereotactic body radiotherapy (SBRT) is commonly used to provide targeted treatment to metastatic lung disease. Investigation is needed to understand the influence of histology on treatment outcomes. We report how tumor histology affects local control (LC) in a cohort of patients with n...
Autores principales: | Allen, Alexander J., Labella, Dominic A., Kowalchuk, Roman O., Waters, Michael R., Kersh, Charles R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9903091/ https://www.ncbi.nlm.nih.gov/pubmed/36762063 http://dx.doi.org/10.21037/tlcr-22-538 |
Ejemplares similares
-
Stereotactic body radiation therapy in the treatment of ovarian cancer
por: Kowalchuk, Roman O., et al.
Publicado: (2020) -
Low‐dose hilar and mediastinal stereotactic body radiation therapy for non‐small cell lung cancer: Analysis of outcomes in patients receiving one or multiple courses of treatment
por: Kowalchuk, Roman O., et al.
Publicado: (2020) -
Stereotactic Body Radiotherapy for Oligometastatic Disease in Non-small Cell Lung Cancer
por: Wujanto, Caryn, et al.
Publicado: (2019) -
Stereotactic body radiation therapy for empirically treated hypermetabolic lung lesions: a single-institutional experience identifying the Charlson score as a key prognostic factor
por: Kowalchuk, Roman O., et al.
Publicado: (2020) -
Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence
por: Decaestecker, Karel, et al.
Publicado: (2014)